Rate My Professor Mark McEvoy

Conjoint Associate Professor Mark McEvoy serves as a principal epidemiologist and public health researcher in the School of Medicine and Public Health within the Faculty of Health and Medicine at the University of Newcastle. He earned his Doctor of Philosophy, Bachelor of Science, Graduate Diploma in Genetic Counselling, and Master of Medical Science in Clinical Epidemiology from the University of Newcastle. His career at the institution spans over two decades, beginning as a Research Officer in the Newcastle Institute of Public Health from 2001 to 2003, followed by Research Fellow in the School of Medicine and Public Health-Epidemiology from 2004 to 2006, and Lecturer since 2007. He concurrently holds a Conjoint Associate Professor position at La Trobe University’s Rural Health School.

McEvoy's research focuses on cardiovascular disease, chronic disease, epidemiology, gastrointestinal disorders, genetic epidemiology, methylarginines, microbiome, molecular epidemiology, and public health. He has contributed to over 300 peer-reviewed publications, including 'Prevention of Adverse Cardiovascular Events Using the 23-Valent Pneumococcal Polysaccharide Vaccine: A Randomized Clinical Trial' (JAMA Cardiology, 2025), 'Long-Term Sequelae of COVID-19: A Systematic Review and Meta-Analysis of Symptoms 3 Years Post-SARS-CoV-2 Infection' (Journal of Medical Virology, 2025), 'The role of inorganic nitrate and nitrite in CVD' (Nutrition Research Reviews, 2017), and numerous genome-wide association studies identifying loci for kidney function, endometrial cancer, and fibrinogen concentration. With an h-index of 68, over 12,800 citations on ResearchGate, and ranking in the top 3.4% of epidemiologists globally per Expertscape, his work has substantially advanced knowledge in nutritional interventions, genetic risk factors for chronic conditions, and population health outcomes through involvement in cohorts like the Hunter Community Study and international meta-analyses.